BD (Becton, Dickinson and Company), a leading global medical technology company, is advancing the future of healthcare delivery through its Connected Care strategy an integrated ecosystem designed to improve clinical outcomes, operational efficiency, and predictive, precision-based care across healthcare settings.
At the centre of BD’s Connected Care approach are three strategic pillars that together create a seamless and intelligent care continuum.
Pharmacy Automation
The first pillar focuses on Pharmacy Automation, featuring advanced technologies such as automated pill packaging, single-dose medication preparation, and robotic storage optimisation. These solutions are deployed across retail, hospital, and central fill pharmacies to improve medication safety, efficiency, and workflow accuracy while reducing the burden on healthcare professionals.
Medication Management Solutions
The second pillar centres on Medication Management Solutions, led by BD’s globally recognised Alaris infusion platform. The platform supports safer and more accurate medication delivery, enabling clinicians to administer treatments with greater precision, confidence, and control.
Advanced Patient Monitoring
The third pillar, Advanced Patient Monitoring, builds on capabilities recently acquired from Edwards Lifesciences and focuses on haemodynamic monitoring and cardiac insights. Through non-invasive, minimally invasive, and invasive technologies, BD enables clinicians to gain deeper visibility into a patient’s cardiovascular condition, supporting faster and more informed interventions.
Advancing Connected Care Through AI
“BD’s vision extends beyond optimising standalone systems. The company is building an integrated system layer that connects data across devices and care settings. By enabling AI-driven predictive analytics and advanced hypotension monitoring tools, BD aims to shift healthcare from reactive to proactive care models,” said Bilal Muhsin, Executive Vice President and President of the Connected Care Segment at BD.
Through this integration, clinicians can anticipate patient deterioration before complications become critical. BD’s combined expertise in medication delivery and real-time patient monitoring enables the development of a closed-loop system that continuously informs clinicians about treatment effectiveness and patient status.
Also read: Mediclinic Middle East and MetLife partner to deliver nationwide access to virtual care
Driving Measurable Clinical Outcomes
BD Connected Care is designed to improve healthcare performance and patient wellbeing by reducing hospital length of stay, lowering ICU and hospital readmissions, and enhancing overall patient outcomes.
“By integrating actionable data insights with clinical decision support tools, BD empowers healthcare providers to deliver proactive, precision-based care tailored to individual patient needs. The result is improved safety, greater efficiency, and more sustainable healthcare systems,” added Bilal Muhsin.
Extending Care Beyond Hospitals
As healthcare increasingly expands into home care and lower-acuity settings, BD is extending its Connected Care framework beyond traditional hospitals. The company is developing a continuous, cloud-based, AI-enabled platform designed to support monitoring and treatment across multiple care environments.
“This approach ensures continuity of care regardless of location, enabling patients to receive consistent, high-quality monitoring and support whether they are in hospital, at home, or in outpatient facilities,” concluded Bilal Muhsin.
Through its Connected Care strategy, BD is redefining how healthcare systems integrate technology, data, and clinical expertise to advance a more predictive, connected, and patient-centred future of care.
